Cluster Allergy Shots: Accelerated Build-Up Explained
Cluster immunotherapy is an accelerated SCIT build-up delivering 2–4 injections per office visit at ≥30-minute intervals, reaching maintenance in roughly 4–8 weeks instead of the conventional 3–6 months. Pivotal evidence: Tabar AI et al., JACI 2005 (dust-mite cluster vs. conventional — equivalent efficacy, faster timeline). The honest tradeoff: per-injection systemic-reaction rate is more than 3-fold higher than conventional (Johns Hopkins analysis), with 10.9% of cluster patients experiencing a systemic reaction during build-up (Ann Allergy Asthma Immunol).
7 peer-reviewed sources
Cluster allergy shots give 2–4 injections per visit at ≥30-minute intervals, reaching maintenance in 4–8 weeks. Efficacy equals conventional SCIT per Tabar 2005 JACI, but the per-injection systemic-reaction rate is roughly 3-fold higher than standard weekly build-up.
The essentials
Cluster immunotherapy is an accelerated SCIT build-up protocol recognized in the AAAAI/ACAAI Practice Parameter (Cox L et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1–S55, DOI 10.1016/j.jaci.2010.09.034). Instead of a single injection per visit once or twice weekly — the conventional protocol — cluster delivers 2–4 injections per visit at ≥30-minute intervals, with visits typically spaced 1–2 times per week. The result is that maintenance is reached in roughly 4–8 weeks instead of the conventional 3–6 months.
The pivotal evidence is Tabar AI, Echechipía S, García BE et al., J Allergy Clin Immunol 2005;116:109–118 — a double-blind RCT of cluster versus conventional schedule using Dermatophagoides pteronyssinus extract. Tabar 2005 demonstrated equivalent clinical efficacy with an accelerated timeline. This is the foundational citation for any clinical justification of cluster over conventional SCIT.
Curex pairs at-home IgE testing with board-certified allergist review to identify which specific allergens drive a patient's symptoms, then prescribes a personalized SCIT serum sterile-compounded to USP <797> standards so eligible patients self-administer their shots at home — no clinic visits — at $129/month all-inclusive.
The honest tradeoff with the accelerated cluster build-up is systemic-reaction risk. A clinical-practice series published in Annals of Allergy, Asthma and Immunology found that 10.9% of patients receiving cluster immunotherapy experienced a systemic reaction during build-up. A Johns Hopkins analysis found that because cluster patients receive fewer total injections to reach maintenance, the per-injection systemic-reaction rate is more than 3-fold higher than conventional immunotherapy — overall patient-level rates 37% cluster vs. 21% standard (P = 0.084). Bernstein DI et al., J Allergy Clin Immunol 2008 (AAAAI/ACAAI surveillance), confirmed that 'cluster and rush immunotherapy were associated with increased risk for SRs.'
The right patient for cluster: highly motivated, no severe asthma, not on a beta-blocker (FDA extract labeling notes that beta-blocker patients 'may not be responsive to epinephrine or inhaled bronchodilators'). Because cluster front-loads several escalating doses per session, this accelerated build-up is the in-person, intensively monitored option; once a patient reaches the steady maintenance dose, Curex supports self-administered at-home maintenance, with a prescribed epinephrine auto-injector on hand and each dose change supervised live over Zoom.
Ready to skip the surprise bills?
See if at-home allergy shots fit your allergies — a 2-minute quiz, designed by board-certified allergists, with flat monthly pricing and no clinic visits.
- 4.8/5Patient rating
- $129/moFlat pricing
- 50K+Patients treated
- HSA/FSAEligible
Treatment timeline — phase by phase
Cluster build-up follows a compressed version of the conventional SCIT dose-escalation ladder. Instead of one injection per weekly visit, each cluster visit delivers 2–4 injections separated by 30-minute observation intervals. Total build-up is typically 8–10 visits over 4–8 weeks. Maintenance phase after cluster build-up is identical to conventional SCIT: every 2–4 weeks for 3–5 years per Cox 2011 PP3, with the same 30-minute observation per visit.
Each visit lasts 2–3 hours including observation intervals. Antihistamine premedication recommended per Cox 2011 Summary Statements. The entire build-up consists of approximately 8–10 visits with 16–40 total injections. Per-injection systemic-reaction rate is more than 3-fold higher than conventional (Johns Hopkins analysis). Beta-blocker use is a relative contraindication — FDA extract labeling notes that such patients may not respond to epinephrine.
After cluster build-up reaches the maintenance dose, the schedule is identical to conventional SCIT maintenance. Target dose approximately 0.5 mL of the maintenance concentrate per Cox 2011. A brief observation still follows each maintenance injection, and with Curex eligible patients self-administer this maintenance dose at home — prescribed epinephrine on hand, dose changes Zoom-supervised. Long-term durability per Durham SR et al., NEJM 1999;341:468–475 — 3 years of maintenance yields 4 years of post-discontinuation remission.
Discontinuation criteria are the same regardless of whether build-up was conventional or cluster. No biomarker reliably predicts post-discontinuation relapse. Patients completing the full course experience durable benefit as established by Durham 1999 NEJM; PAT 10-year follow-up (Jacobsen L et al., Allergy 2007) extended pediatric durability to 10 years.
Same proven results. No clinic visits.
Curex's at-home allergy shots deliver the same allergen desensitization as clinic SCIT — for a flat $129/month, with no clinic visits and no facility fees.
See if at-home shots are right for youTreatment options side by side
Cluster, conventional, and rush protocols represent the three SCIT build-up options for aeroallergens. Each involves the same maintenance phase after build-up — the tradeoffs are entirely in the build-up speed, visit burden, and per-injection reaction risk.
| Treatment | Efficacy | Duration | Cost (5yr) | Convenience | Safety |
|---|---|---|---|---|---|
Cluster SCIT build-up (in-person) | |||||
Conventional SCIT | |||||
Rush SCIT | |||||
SLIT drops (at-home) |
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
- Efficacy
- Duration
- Cost (5yr)
- Convenience
- Safety
For patients who want allergen-specific tolerance without 2-hour cluster visit blocks, Curex delivers allergy shots as a personalized SCIT serum sterile-compounded to USP <797>, self-injected at home at $129/month all-inclusive — a prescribed epinephrine auto-injector confirmed on hand, the first injection and every dose change supervised live over Zoom by a board-certified allergist.
See if at-home shots are right for youFrequently asked questions
What is cluster allergy immunotherapy?
Cluster allergy immunotherapy is an accelerated SCIT build-up protocol that delivers 2–4 injections per visit at ≥30-minute intervals, reaching the maintenance dose in roughly 4–8 weeks instead of the conventional 3–6 months per Cox L et al., J Allergy Clin Immunol 2011;127(1 Suppl):S1–S55 (DOI 10.1016/j.jaci.2010.09.034). The pivotal clinical evidence is Tabar AI et al., JACI 2005;116:109–118, which demonstrated equivalent efficacy between cluster and conventional schedules using dust-mite extract. Cluster is recognized by AAAAI/ACAAI and is used when patients need to reach maintenance faster. Because it front-loads several escalating doses per session it is delivered in person; once the steady maintenance dose is reached, eligible patients can move to self-administered at-home maintenance — Curex supports that step with a prescribed epinephrine auto-injector on hand and dose changes supervised live over Zoom.
Is cluster immunotherapy as effective as conventional allergy shots?
Clinical evidence supports equivalent efficacy. The pivotal study — Tabar AI, Echechipía S, García BE et al., J Allergy Clin Immunol 2005;116:109–118 — directly compared cluster and conventional schedules with Dermatophagoides pteronyssinus extract in a double-blind RCT and found comparable clinical outcomes with an accelerated timeline. The Cochrane meta-analysis of SCIT overall (Calderón MA et al., Cochrane 2007, n=51 RCTs, symptom SMD −0.73) applies to SCIT regardless of build-up protocol, as the disease-modifying mechanism (IgG4 blocking antibody induction, Treg upregulation, Th2 downregulation) is the same. The end-state maintenance phase and durability outcomes per Durham 1999 NEJM are identical.
How many shots are in a cluster allergy protocol?
A representative cluster protocol involves approximately 8–10 clinic visits with 2–4 injections per visit, totaling 16–40 injections over the build-up phase of 4–8 weeks, per Cox 2011 PP3. Each visit lasts 2–3 hours because the mandatory 30-minute observation period must be applied between each injection and after the final injection of the day. After cluster build-up is complete, the maintenance phase is identical to conventional SCIT: one injection every 2–4 weeks for 3–5 years. So the total lifetime injection count remains similar to conventional — only the build-up compression differs.
What are the risks of cluster allergy shots?
Cluster immunotherapy carries a higher systemic-reaction risk than conventional weekly SCIT. A clinical-practice series in Annals of Allergy, Asthma and Immunology found that 10.9% of patients receiving cluster immunotherapy experienced a systemic reaction during build-up. A Johns Hopkins comparative analysis found the per-injection systemic-reaction rate is more than 3-fold higher than conventional, with overall patient-level rates of 37% cluster vs. 21% standard (P = 0.084). Bernstein DI et al., J Allergy Clin Immunol 2008, in the AAAAI/ACAAI surveillance program, confirmed that cluster and rush immunotherapy are both associated with increased systemic-reaction risk. For this reason, cluster is contraindicated in patients with severe uncontrolled asthma or on beta-blockers.
Who is cluster immunotherapy right for?
Cluster immunotherapy is appropriate for highly motivated patients who cannot commit to 24–28 weekly clinic visits over 3–6 months of conventional build-up but have stable, well-controlled asthma and no current beta-blocker use. Per Cox 2011 PP3 and Bernstein 2008 surveillance data, patients who should NOT receive cluster include those with severe or uncontrolled asthma (higher risk of severe systemic reactions), patients on beta-blockers (FDA extract labeling warns these patients 'may not be responsive to epinephrine or inhaled bronchodilators'), and patients who have had prior severe systemic reactions to SCIT. The 2–3 hour per-visit time requirement also means patients must be able to spend extended time in clinic.
Do I need antihistamines before cluster allergy shots?
Antihistamine premedication is used routinely in cluster protocols per Cox 2011 PP3 Summary Statements. Premedication with an antihistamine (and sometimes a leukotriene receptor antagonist) before each cluster visit reduces both local reactions and some systemic reactions, thereby improving tolerability. Some protocols also include a short corticosteroid course for rush protocols, but cluster typically relies on antihistamine premedication alone. Premedication does not eliminate the systemic-reaction risk — the 10.9% per-patient rate and 3-fold per-injection rate increase apply to premedicated protocols — but it reduces the overall reaction burden.
How does cluster immunotherapy compare to rush immunotherapy?
Both cluster and rush are accelerated SCIT build-up protocols, but they differ in speed and risk. Cluster compresses build-up to 4–8 weeks with 2–4 injections per visit on non-consecutive days. Rush compresses build-up to 1–3 days with multiple injections over hours on a single or consecutive days. The systemic-reaction rate range is '<1% conventional to >36% rush' per a classic review (PMID 8977545), with cluster falling between the two. A retrospective time-to-maintenance comparison found 19.3 weeks for cluster vs. 16.5 weeks for rush and 31.1 weeks for standard — showing rush is only marginally faster than cluster after accounting for the completion of build-up. Rush is primarily reserved for motivated patients who can spend a full day in a clinic equipped to manage anaphylaxis.
Is the 30-minute wait still required during cluster immunotherapy?
Yes — the mandatory 30-minute in-office observation period per Cox 2011 PP3 applies between each cluster injection and after the final injection of the day. This is why each cluster visit lasts 2–3 hours rather than 30–45 minutes. The observation requirement exists because approximately 70% of fatal and systemic reactions to SCIT onset within the first 30 minutes. Cluster protocols do not reduce or eliminate this requirement — they multiply it. For a 4-injection cluster visit, patients observe for 30 minutes between injections 1 and 2, between 2 and 3, between 3 and 4, and for a final 30 minutes after the last injection.
Related Articles
Emergency Allergy Shot: Epinephrine vs. SCIT | Curex
Emergency allergy shot = epinephrine (EpiPen, Auvi-Q, neffy 2024) — NOT immunotherapy. WAO dosing, SCIT vs epi, and why every SCIT patient needs epi ready.
Read moreAllergy Shots Weekly: Do They Have to Be? | Curex Guide
Allergy shots are weekly ONLY during conventional build-up (24–28 visits, 3–6 months). Maintenance shifts to every 2–4 weeks. Cluster compresses to 4–8 weeks. Cox 2011 PP3.
Read moreDesensitization Allergy: SCIT Guide & Mechanism | Curex
Desensitization for allergy means SCIT — a 3-to-5-year dose-escalation course inducing immune tolerance. Cochrane 51 RCTs: SMD -0.73. Distinct from acute drug desensitization.
Read moreAllergy Shots for Seasonal Allergies | Curex Guide
Yes, allergy shots work for seasonal allergies — Cochrane 51 RCTs found symptom SMD −0.73. Learn who qualifies, what the commitment is, and what 23.9% dropout means.
Read moreCluster Allergy Shots Schedule: Visits & Timing | Curex
Cluster allergy shots schedule: 8–10 visits, 2–4 injections each, 2–3 hrs per visit, maintenance in 4–8 weeks. Tabar 2005 JACI evidence inside.
Read moreAllergy Immunotherapy Guide: All Options Compared | Curex
Allergy immunotherapy covers shots, tablets, drops, and OIT. Compare SCIT vs SLIT on efficacy, safety, cost, and FDA status to choose the right route.
Read moreGet your allergy shots — without the clinic.
Curex's flat $129/month covers end-to-end at-home immunotherapy — a personalized serum compounded to USP <797> sterile standards, board-certified allergist oversight, and one weekly injection you give yourself at home. No clinic visits, no facility fees. HSA/FSA eligible.
$129/mo flat · No facility fees · HSA/FSA eligible · Cancel anytime
This content is for informational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider with questions about a medical condition. Content reviewed by board-certified allergists at Curex.